OTCMKTS:EKTAY

Elekta AB (publ) - EKTAY Stock Forecast, Price & News

$5.78

+0.12 (+2.12%)

(As of 11/29/2022 12:00 AM ET)

Add

Compare

Today's Range: $5.74
▼
$5.80
50-Day Range: $4.77
▼
$5.87
52-Week Range: $4.68
▼
$12.96

Volume: 20,182 shs
Average Volume: 29,635 shs
Market Capitalization: $2.22 billion

P/E Ratio: 17.51
Dividend Yield: 2.70%
Price Target: $69.00

Elekta AB (publ) MarketRank™ Forecast

Analyst Rating: Reduce
1.25 Rating Score
Upside/Downside: 1,094.3% Upside
$69.00 Price Target
Short Interest: Healthy
0.00% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 1.55
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 28.57%
From $0.28 to $0.36 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.99 out of 5 stars

2.6

Analyst's Opinion

Consensus Rating
Elekta AB (publ) has received a consensus rating of Sell. The company's average rating score is 1.25, and is based on no buy ratings, 1 hold rating, and 3 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $69.00, Elekta AB (publ) has a forecasted upside of 1,094.3% from its current price of $5.78.
Amount of Analyst Coverage
Elekta AB (publ) has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.00% of the outstanding shares of Elekta AB (publ) have been sold short.
Short Interest Ratio / Days to Cover
Elekta AB (publ) has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Elekta AB (publ) has recently decreased by 84.46%, indicating that investor sentiment is improving significantly.

2.5

Dividend Strength

Dividend Yield
Elekta AB (publ) pays a meaningful dividend of 2.70%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Elekta AB (publ) does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Elekta AB (publ) is 45.45%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Elekta AB (publ) will have a dividend payout ratio of 41.67% next year. This indicates that Elekta AB (publ) will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for EKTAY.

3.6

News and Social Media Coverage

News Sentiment
Elekta AB (publ) has a news sentiment score of 1.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Elekta AB (publ) this week, compared to 0 articles on an average week.
MarketBeat Follows
2 people have added Elekta AB (publ) to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Elekta AB (publ) insiders have not sold or bought any company stock.
Percentage Held by Insiders
41.28% of the stock of Elekta AB (publ) is held by insiders. A high percentage of insider ownership can be a sign of company health.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Elekta AB (publ) are expected to grow by 28.57% in the coming year, from $0.28 to $0.36 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Elekta AB (publ) is 17.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.14.
Price to Earnings Ratio vs. Sector
The P/E ratio of Elekta AB (publ) is 17.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 94.19.
Price to Book Value per Share Ratio
Elekta AB (publ) has a P/B Ratio of 2.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Elekta AB (publ) (OTCMKTS:EKTAY) Stock

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

EKTAY Stock News Headlines

November 24, 2022 | finance.yahoo.com

European shares struggle for direction as traders weigh rate outlook

November 5, 2022 | finance.yahoo.com

Elekta AB (publ) (EKTAY)

October 13, 2022 | finance.yahoo.com

Elekta AB (publ) (EKTA-B.ST)

October 9, 2022 | fool.com

ELEKTA B SHS ADR (OTC: EKTAY)

October 2, 2022 | reuters.com

Elekta AB (publ)

August 27, 2022 | seekingalpha.com

Elekta AB (publ) 2023 Q1 - Results - Earnings Call Presentation

August 25, 2022 | seekingalpha.com

Elekta AB (publ) (EKTAF) Q1 2023 Earnings Call Transcript

August 25, 2022 | finance.yahoo.com

Edited Transcript of EKTAb.ST earnings conference call or presentation 25-Aug-22 8:00am GMT

May 15, 2022 | seekingalpha.com

Elekta (EKTAY) Presents at ESTRO 2022

February 24, 2022 | finance.yahoo.com

Elekta: Interim report, May-January 2021/22

January 7, 2022 | seekingalpha.com

New finance chief at Elekta

January 7, 2022 | finance.yahoo.com

Elekta to appoint Tobias Hägglöv as Chief Financial Officer

December 14, 2021 | seekingalpha.com

EKTAY

December 3, 2021 | finance.yahoo.com

Elekta's new sustainability-linked bond oversubscribed

November 25, 2021 | nasdaq.com

Elekta flags component shortage ahead after profit beats forecasts

November 25, 2021 | finance.yahoo.com

More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac

November 4, 2021 | finance.yahoo.com

Invitation to the presentation of Elekta's second quarter 2021/22

October 29, 2021 | finance.yahoo.com

Elekta establishes a framework for sustainability-linked bonds

August 25, 2021 | seekingalpha.com

Elekta AB (publ) reports FQ1 results

August 25, 2021 | finance.yahoo.com

Report from the Annual General Meeting 2021 in Elekta

July 23, 2021 | finance.yahoo.com

GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices

July 21, 2021 | markets.businessinsider.com

Notice to the Annual General Meeting of Elekta AB (publ)

July 7, 2021 | finance.yahoo.com

Elekta optimizes treatment times for cancer patients via proactive service innovation

June 17, 2021 | finance.yahoo.com

Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

June 7, 2021 | finance.yahoo.com

Elekta's new strategy to focus on growth and access to radiation therapy

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

EKTAY Company Calendar

Ex-Dividend for 9/16 Dividend: 8/26/2022
Dividend Payable: 9/16/2022
Today: 11/30/2022
Fiscal Year End: 4/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:EKTAY
CUSIP: N/A
CIK: 1451160
Web: www.elekta.com
Phone: (685) 872-5400
Fax: 46-8-587-255-00
Employees: 4,826
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $69.00
High Stock Price Forecast: $69.00
Low Stock Price Forecast: $69.00
Forecasted Upside/Downside: +1,094.3%
Consensus Rating: Reduce
Rating Score (0-4): 1.25
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.33
Trailing P/E Ratio: 17.51
Forward P/E Ratio: 20.63
P/E Growth: N/A
Net Income: $129.94 million
Net Margins: 7.45%
Pretax Margin: 9.81%
Return on Equity: 15.46%
Return on Assets: 5.00%

Debt

Debt-to-Equity Ratio: 0.45
Current Ratio: 1.08
Quick Ratio: 0.82

Sales & Book Value

Annual Sales: $1.64 billion
Price / Sales: 1.35
Cash Flow: $0.68 per share
Price / Cash Flow: 8.45
Book Value: $2.72 per share
Price / Book: 2.12

Miscellaneous

Outstanding Shares: 383,570,000
Free Float: 225,231,000
Market Cap: $2.22 billion
Optionable: Not Optionable
Beta: 1.03

Key Executives

Dr. Laurent Leksell (Age 70)
Founder & Chairman

Mr. Gustaf Salford (Age 45)
Pres & CEO

Mr. Tobias Hagglov (Age 44)
Chief Financial Officer

Cecilia Ketels
Head of Investor Relations

Mr. Jonas Bolander (Age 56)
Exec. VP of Group Functions, Sec. & Gen. Counsel

Mr. Mattias Thorsson
VP and Head of Corp. Communications & Public Affairs

Mr. James P. Hoey (Age 64)
Head of External Relations

Mr. John Lapré (Age 58)
Pres of Brachy & Neuro Solutions

Mr. Maurits Wolleswinkel (Age 51)
Chief Product Officer

Mr. Anming Gong (Age 58)
Exec. VP of Region China

Key Competitors

View All Competitors

EKTAY Stock - Frequently Asked Questions

Should I buy or sell Elekta AB (publ) stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last twelve months. There are currently 3 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" EKTAY shares.
View EKTAY analyst ratings or view top-rated stocks.
What is Elekta AB (publ)'s stock price forecast for 2023?: 4 equities research analysts have issued 12 month price targets for Elekta AB (publ)'s stock. Their EKTAY share price forecasts range from $69.00 to $69.00. On average, they anticipate the company's share price to reach $69.00 in the next twelve months. This suggests a possible upside of 1,094.3% from the stock's current price.
View analysts price targets for EKTAY or view top-rated stocks among Wall Street analysts.
How have EKTAY shares performed in 2022?: Elekta AB (publ)'s stock was trading at $12.80 on January 1st, 2022. Since then, EKTAY stock has decreased by 54.9% and is now trading at $5.7775.
View the best growth stocks for 2022 here.
Are investors shorting Elekta AB (publ)?: Elekta AB (publ) saw a decrease in short interest in November. As of November 15th, there was short interest totaling 3,900 shares, a decrease of 84.5% from the October 31st total of 25,100 shares. Based on an average daily trading volume, of 69,800 shares, the short-interest ratio is presently 0.1 days.
View Elekta AB (publ)'s Short Interest.
How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)?: Elekta AB (publ) declared a dividend on Tuesday, August 23rd. Investors of record on Monday, August 29th will be paid a dividend of $0.0809 per share on Friday, September 16th. This represents a yield of 2.43%. The ex-dividend date of this dividend is Friday, August 26th. This is a positive change from the stock's previous dividend of $0.08.
Read our dividend analysis for EKTAY.

Is Elekta AB (publ) a good dividend stock?: Elekta AB (publ) (OTCMKTS:EKTAY) pays an annual dividend of $0.15 per share and currently has a dividend yield of 2.70%. The dividend payout ratio is 45.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EKTAY will have a dividend payout ratio of 41.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EKTAY.
What is Elekta AB (publ)'s stock symbol?: Elekta AB (publ) trades on the OTCMKTS under the ticker symbol "EKTAY."
How do I buy shares of Elekta AB (publ)?: Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Elekta AB (publ)'s stock price today?: One share of EKTAY stock can currently be purchased for approximately $5.78.
How much money does Elekta AB (publ) make?: Elekta AB (publ) (OTCMKTS:EKTAY) has a market capitalization of $2.22 billion and generates $1.64 billion in revenue each year. The company earns $129.94 million in net income (profit) each year or $0.33 on an earnings per share basis.
How many employees does Elekta AB (publ) have?: The company employs 4,826 workers across the globe.
How can I contact Elekta AB (publ)?: Elekta AB (publ)'s mailing address is P.O. Box 7593, Stockholm V7, SE-103 93. The official website for the company is www.elekta.com. The company can be reached via phone at (685) 872-5400, via email at cecilia.ketels@elekta.com, or via fax at 46-8-587-255-00.

This page (OTCMKTS:EKTAY) was last updated on 11/30/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial